Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU)
Lluís Masana; José López Miranda; Fernando Civeira; Leonardo Reinares; Carlos Guijarro; Núria Plana; Rafael Cuenca; Demetrio Sánchez; José Luis Hernández; Raimundo Andrés; Agustín Blanco; Santiago Villamayor;
Clin Investig Arterioscler. 2020;32:183-92
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines
Pedro Armario; Carlos Brotons; Roberto Elosua; Maria Alonso de Leciñana; Almudena Castro; Albert Clarà; Olga Cortés; Ángel Díaz Rodriguez; María Herranz; Soledad Justo; Carlos Lahoz; Juan Pedro-Botet; Antonio Pérez Pérez; Rafael Santamaria; Ricard Tresserras; Susana Aznar Lain; Miguel Ángel Royo-Bordonada;
Clin Investig Arterioscler. 2021;33:85-107
Dyslipidemia treatment strategies in primary and secondary prevention. Dyslipemia Registry of the Spanish Arteriosclerosis Society
Victoria Marco-Benedí; Ana M. Bea; Rosa M. Sánchez Hernández; Núria Plana; Pedro Valdivielso; Fernando Civeira;
Clin Investig Arterioscler. 2022;34:303-10